Synergic effect of curcumin or lycopene with irradiation upon oral squamous cell carcinoma cells

被引:14
作者
Camacho-Alonso, F. [1 ]
Lopez-Jornet, P. [1 ]
Tudela-Mulero, M. R. [1 ]
机构
[1] Univ Murcia, Dept Oral Med, Murcia, Spain
关键词
curcumin; lycopene; squamous cell carcinoma; irradiation; in vitro cell line; SEMIAUTOMATED COLORIMETRIC ASSAY; MATRIX METALLOPROTEINASES; LIPID-PEROXIDATION; LARYNGEAL-CANCER; HUMAN HEALTH; HEAD; INHIBITION; EXPRESSION; GROWTH; RISK;
D O I
10.1111/odi.12025
中图分类号
R78 [口腔科学];
学科分类号
100302 [口腔临床医学];
摘要
OBJECTIVE: An in vitro study was carried out to evaluate the effect of curcumin, lycopene, and irradiation upon oral squamous cell carcinoma (OSCC). MATERIALS AND METHODS: Curcumin and lycopene were administrated at doses of 3, 4.25, 5.50, and 6.75 mu M in PE/CA-PJ15 OSCC cultures irradiated with different doses (1, 2.5, and 5 Gy), followed by evaluation of the effects upon cell viability, apoptosis, and migration after 24, 48, and 72 h of incubation. RESULTS: The application of curcumin or lycopene to the tumor cells during 24, 48, and 72 h without irradiation exerted an inhibitor effect upon cell viability and increased cell apoptosis. The maximum reduction in cell viability and the peak apoptotic effect was recorded with the 5.50 and 6.75 mu M doses, for both curcumin and lycopene. Likewise, curcumin and lycopene exerted a synergic effect upon both variables on applying irradiation. Lastly, the 5.50 and 6.75 mu M drug doses, together with 5 Gy of irradiation, yielded the greatest decrease in cell migration capacity with both curcumin and lycopene. CONCLUSIONS: Curcumin and lycopene increase cytotoxic activity in the PE/CA-PJ15 cell line and reduce cell migration capacity, while the combination of curcumin or lycopene with irradiation exerts a synergic effect.
引用
收藏
页码:465 / 472
页数:8
相关论文
共 61 条
[1]
Agarwal S, 2000, CAN MED ASSOC J, V163, P739
[2]
Molecular targets of dietary agents for prevention and therapy of cancer [J].
Aggarwal, BB ;
Shishodia, S .
BIOCHEMICAL PHARMACOLOGY, 2006, 71 (10) :1397-1421
[3]
From chemoprevention to chemotherapy: common targets and common goals [J].
Aggarwal, BB ;
Takada, Y ;
Oommen, OV .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2004, 13 (10) :1327-1338
[4]
Aggarwal BB, 2003, ANTICANCER RES, V23, P363
[5]
Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-κB signaling [J].
Aggarwal, S ;
Takada, Y ;
Singh, S ;
Myers, JN ;
Aggarwal, BB .
INTERNATIONAL JOURNAL OF CANCER, 2004, 111 (05) :679-692
[6]
CURCUMIN - A POTENT INHIBITOR OF LEUKOTRIENE-B4 FORMATION IN RAT PERITONEAL POLYMORPHONUCLEAR NEUTROPHILS (PMNL) [J].
AMMON, HPT ;
ANAZODO, MI ;
SAFAYHI, H ;
DHAWAN, BN ;
SRIMAL, RC .
PLANTA MEDICA, 1992, 58 (02) :226-226
[7]
Salivary analysis in oral cancer patients - DNA and protein oxidation, reactive nitrogen species, and antioxidant profile [J].
Bahar, Gideon ;
Feinmesser, Raphael ;
Shpitzer, Thomas ;
Popovtzer, Aaron ;
Nagler, Rafael M. .
CANCER, 2007, 109 (01) :54-59
[8]
ZD1839 ('Iressa')1,2 as an anticancer agent [J].
Baselga, J ;
Averbuch, SD .
DRUGS, 2000, 60 (Suppl 1) :33-40
[9]
Evaluation of oxidative stress and nitric oxide levels in patients with oral cavity cancer [J].
Beevi, SSS ;
Rasheed, AMH ;
Geetha, A .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2004, 34 (07) :379-385
[10]
CARMICHAEL J, 1987, CANCER RES, V47, P943